Evaluation index for non-human primate SARS-CoV-2 infection models
Author:
Affiliation:

Wuhan Institute of Biological Products Co. , Ltd, Biosafety Level 3 Laboratory, Wuhan 430207, China

Clc Number:

R-33

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    With the outbreak of the novel coronavirus pneumonia, coronavirus disease 2019 ( COVID-19), research on the pathogenesis and functional structure of the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as on COVID-19-related vaccines and drugs, has accelerated rapidly. Animal infection models, especially those using non-human primates, are indispensable for research on COVID-19. Owing to their physiological similarity to humans, non-human primate models are among the most important animal models in SARS-CoV-2 research. However, there are relatively few studies using non-human primate infection models for COVID-19 owing to various constraints, including ethics, research qualifications, and cost; therefore, it is particularly critical to ensure the validity of each animal test result . This article summarizes and analyzes evaluation indicators for the non-human primate model of SARS-CoV-2 infection, including clinical scores, imaging diagnosis, hematology indicators, and pathogens, from the published literature on SARS-CoV-2-infected animal models and clinical data, which could provide a useful reference for the successful establishment of more effective non-human primate models of SARS-CoV-2 infection.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 29,2021
  • Revised:
  • Adopted:
  • Online: August 01,2022
  • Published: